# Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery

> **NCT05113979** · — · COMPLETED · sponsor: **OnPoint Vision Inc** · enrollment: 10 (actual)

## Conditions studied

- Refractive Errors

## Interventions

- **DEVICE:** AccuraSee IOPCL with +3.0D add

## Key facts

- **NCT ID:** NCT05113979
- **Lead sponsor:** OnPoint Vision Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-09
- **Primary completion:** 2022-09-09
- **Final completion:** 2022-09-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05113979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05113979, "Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05113979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*